A high neutrophil-to-lymphocyte ratio (NLR) has been identified as a poor prognostic factor in ovarian cancer, with increased IL6 levels being associated with a higher NLR and worse clinical outcomes [115]. The gene discussed is IL6; the disease is ovarian cancer.